| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6157634 | American Journal of Kidney Diseases | 2013 | 10 Pages |
Abstract
IV iron sucrose at a dose of 0.5 mg/kg at the intervals prescribed is noninferior to higher doses in maintaining hemoglobin levels >10.5 g/dL in children, adolescents, and young adults receiving ESA therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Stuart L. MD, David PhD, Bradley A. MD,